August 20, 2025

Wide Disparities in IRD Diagnosis

Nationwide study shows jump in prevalence of IRDs

The Ophthalmologist

August 17, 2025

FDA Affirms Safety of PFAS-Based Materials in Medical Devices

PFAS used in medical devices are different from the small-molecule PFAS that have been linked to environmental and health concerns.

Contact Lens Spectrum

August 14, 2025

Three Lifestyle Behaviors Linked with Cataract Development

Poor sleep, low physical activity (PA), and high sedentary behavior (SB) were found to be both independently and jointly linked with an increased risk of cataract, according to a recent cross-sectional analysis, published in BMC Medicine.

Optometric Management

August 12, 2025

Ocular Therapeutix Announces FDA Approves NPDR Trial Plan for OTX-TKI

A Special Protocol Assessment (SPA) establishes a regulatory path for Ocular Therapeutix’s Axpaxli in diabetic eye disease.

Ophthalmology Management

August 12, 2025

Predicting Normal-Tension Glaucoma

New IOVS study recommends a polygenic approach towards advancing risk stratification in normal-tension glaucoma

The Ophthalmologist

August 11, 2025

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME

The positive results from the SPECTRA trial demonstrate the tolerability and consistent, durable clinical activity of 4D-150 in DME.

Ophthalmology Management

August 07, 2025

Medical Oddities: Cocoa Fights the Flu?

Chocolate fights flu, snails regrow eyes, guts go neural, and past lives go clinical.

Conexiant

August 06, 2025

SCHWIND PresbyMAX: A Universe of Possibilities

Enhancing outcomes in presbyopic laser vision correction

The Ophthalmologist

August 05, 2025

Large US Study Adds to Connection Between NAION Risks and GLP-1 Drugs

Semaglutide and liraglutide showed the highest risk, while dulaglutide and exenatide were not significantly associated with NAION.

Ophthalmology Management